Application of exposure bracketing to streamline the development of contraceptive products.
Contracept X
; 4: 100072, 2022.
Article
em En
| MEDLINE
| ID: mdl-35243326
BMGF, The Bill & Melinda Gates Foundation; Contraceptive development; Exposure-bracketing; FDA, US Food and Drug Administration; LNG, Levonorgestrel; Levonorgestrel; MHRA, UK's Medical and Healthcare Products Regulatory Agency; PD, Pharmacodynamics; PK, Pharmacokinetics; Pharmacokinetics; Progestin; RWDA, real world data analyses; Real world data
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Contracept X
Ano de publicação:
2022
Tipo de documento:
Article